Non-Invasive combo therapy aims to restore bladder function in spinal cord injury

NCT ID NCT07704268

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This trial investigates whether combining high-frequency magnetic stimulation of the sacral nerve roots with ultrasound therapy to the bladder can reduce involuntary bladder contractions in people with spinal cord injury. Participants receive daily treatments for three weeks, and researchers measure changes in bladder capacity and wall elasticity. The goal is to find a non-invasive way to improve bladder control and reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a combination of high-frequency magnetic stimulation and ultrasound therapy applied to the sacral nerve roots and bladder
What this could lead to
If successful, this approach could offer a non-invasive way to improve bladder control and quality of life for people with spinal cord injury.
What could go wrong
This is a small, early-stage trial with only 44 participants, so results may not apply to everyone. The treatment is also time-intensive, requiring daily sessions for three weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rehabilitation Center of Shengjing Hospital, China Medical University, shenyang, Liaoning 110000

    Shenyang, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.